Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gottfried Novacek

Showing results (61-70 of 70) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 70 results.
United European Gastroenterology Journal|July 30, 2020
Use of complementary and alternative medicine and low quality of life associate with the need for psychological and psychotherapeutic interventions in inflammatory bowel diseaseMaximilian Kutschera, Thomas Waldhör, Hans Peter Gröchenig, et al.
Journal of Clinical Medicine|July 29, 2023
Factors Associated with Response to Systemic Corticosteroids in Active Ulcerative Colitis: Results from a Prospective, Multicenter TrialAndreas Blesl, Andrea Borenich, Hans Peter Gröchenig, et al.
Lancet (London, England)|November 4, 2017
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trialJean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, et al.
Inflammatory Bowel Diseases|July 18, 2023
Prediction of Response to Systemic Corticosteroids in Active UC by Microbial Composition-A Prospective Multicenter StudyAndreas Blesl, Philipp Wurm, Silvio Waschina, et al.
Gastroenterology|December 4, 2015
Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative ColitisFranck Carbonnel, Jean Frédéric Colombel, Jérome Filippi, et al.
Inflammatory Bowel Diseases|July 17, 2014
Small bowel adenocarcinomas complicating Crohn's disease are associated with dysplasia: a pathological and molecular studyMagali Svrcek, Gael Piton, Jacques Cosnes, et al.
Journal of Crohn'S & Colitis|December 3, 2010
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situationsGert Van Assche, Axel Dignass, Walter Reinisch, et al.
Journal of Crohn'S & Colitis|November 29, 2023
A Core Outcome Set for Inflammatory Bowel Diseases: Development and Recommendations for Implementation in Clinical Practice Through an International Multi-stakeholder Consensus ProcessLiselotte Fierens, Nicholas Carney, Gottfried Novacek, et al.
Nature Communications|September 12, 2022
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trialDaniel Mrak, Daniela Sieghart, Elisabeth Simader, et al.
Gastroenterology|April 1, 2020
Deep Remission at 1 Year Prevents Progression of Early Crohn's DiseaseRyan C Ungaro, Clara Yzet, Peter Bossuyt, et al.
Pageof 7

Showing results (61-70 of 70) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
United European Gastroenterology Journal|July 30, 2020
Use of complementary and alternative medicine and low quality of life associate with the need for psychological and psychotherapeutic interventions in inflammatory bowel diseaseMaximilian Kutschera, Thomas Waldhör, Hans Peter Gröchenig, et al.
Journal of Clinical Medicine|July 29, 2023
Factors Associated with Response to Systemic Corticosteroids in Active Ulcerative Colitis: Results from a Prospective, Multicenter TrialAndreas Blesl, Andrea Borenich, Hans Peter Gröchenig, et al.
Lancet (London, England)|November 4, 2017
Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trialJean-Frederic Colombel, Remo Panaccione, Peter Bossuyt, et al.
Inflammatory Bowel Diseases|July 18, 2023
Prediction of Response to Systemic Corticosteroids in Active UC by Microbial Composition-A Prospective Multicenter StudyAndreas Blesl, Philipp Wurm, Silvio Waschina, et al.
Gastroenterology|December 4, 2015
Methotrexate Is Not Superior to Placebo for Inducing Steroid-Free Remission, but Induces Steroid-Free Clinical Remission in a Larger Proportion of Patients With Ulcerative ColitisFranck Carbonnel, Jean Frédéric Colombel, Jérome Filippi, et al.
Inflammatory Bowel Diseases|July 17, 2014
Small bowel adenocarcinomas complicating Crohn's disease are associated with dysplasia: a pathological and molecular studyMagali Svrcek, Gael Piton, Jacques Cosnes, et al.
Journal of Crohn'S & Colitis|December 3, 2010
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situationsGert Van Assche, Axel Dignass, Walter Reinisch, et al.
Journal of Crohn'S & Colitis|November 29, 2023
A Core Outcome Set for Inflammatory Bowel Diseases: Development and Recommendations for Implementation in Clinical Practice Through an International Multi-stakeholder Consensus ProcessLiselotte Fierens, Nicholas Carney, Gottfried Novacek, et al.
Nature Communications|September 12, 2022
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trialDaniel Mrak, Daniela Sieghart, Elisabeth Simader, et al.
Gastroenterology|April 1, 2020
Deep Remission at 1 Year Prevents Progression of Early Crohn's DiseaseRyan C Ungaro, Clara Yzet, Peter Bossuyt, et al.
Pageof 7